These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice. Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220 [TBL] [Abstract][Full Text] [Related]
4. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation. Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000 [TBL] [Abstract][Full Text] [Related]
5. Tilianin improves lipid profile and alleviates atherosclerosis in ApoE Du Y; Xi M; Li Y; Zheng R; Ding X; Li X; Zhang X; Wang L; Xing J; Hong B Phytomedicine; 2023 Jan; 109():154577. PubMed ID: 36610166 [TBL] [Abstract][Full Text] [Related]
6. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE Li D; Chen A; Lan T; Zou Y; Zhao L; Yang P; Qu H; Wei L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ FASEB J; 2019 Mar; 33(3):3437-3450. PubMed ID: 30462530 [TBL] [Abstract][Full Text] [Related]
7. Fatostatin inhibits SREBP2-mediated cholesterol uptake via LDLR against selective estrogen receptor α modulator-induced hepatic lipid accumulation. Li M; Lu Q; Zhu Y; Fan X; Zhao W; Zhang L; Jiang Z; Yu Q Chem Biol Interact; 2022 Sep; 365():110091. PubMed ID: 35944649 [TBL] [Abstract][Full Text] [Related]
8. Effect and mechanism of the Ang-(1-7) on human mesangial cells injury induced by low density lipoprotein. Huang W; Tang L; Cai Y; Zheng Y; Zhang L Biochem Biophys Res Commun; 2014 Jul; 450(2):1051-7. PubMed ID: 24978313 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol in LDL receptor recycling and degradation. Yang HX; Zhang M; Long SY; Tuo QH; Tian Y; Chen JX; Zhang CP; Liao DF Clin Chim Acta; 2020 Jan; 500():81-86. PubMed ID: 31770510 [TBL] [Abstract][Full Text] [Related]
11. Welsh onion extract inhibits PCSK9 expression contributing to the maintenance of the LDLR level under lipid depletion conditions of HepG2 cells. Choi HK; Hwang JT; Nam TG; Kim SH; Min DK; Park SW; Chung MY Food Funct; 2017 Dec; 8(12):4582-4591. PubMed ID: 29130084 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic Hallmarks of Fetal Early Atherosclerotic Lesions in Humans. de Nigris F; Cacciatore F; Mancini FP; Vitale DF; Mansueto G; D'Armiento FP; Schiano C; Soricelli A; Napoli C JAMA Cardiol; 2018 Dec; 3(12):1184-1191. PubMed ID: 30419118 [TBL] [Abstract][Full Text] [Related]
13. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651 [TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway. Zheng Y; Tang L; Huang W; Yan R; Ren F; Luo L; Zhang L PLoS One; 2015; 10(8):e0136187. PubMed ID: 26291618 [TBL] [Abstract][Full Text] [Related]
15. SREBP-2, a new target of metformin? Zhang F; Sun W; Chen J; Jiang L; Yang P; Huang Y; Gong A; Liu S; Ma S Drug Des Devel Ther; 2018; 12():4163-4170. PubMed ID: 30584280 [TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis. Vasamsetti SB; Karnewar S; Kanugula AK; Thatipalli AR; Kumar JM; Kotamraju S Diabetes; 2015 Jun; 64(6):2028-41. PubMed ID: 25552600 [TBL] [Abstract][Full Text] [Related]
18. Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2-SR-BI Axis. Ghaffari S; Jang E; Naderinabi F; Sanwal R; Khosraviani N; Wang C; Steinberg BE; Goldenberg NM; Ikeda J; Lee WL Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):200-216. PubMed ID: 33054399 [TBL] [Abstract][Full Text] [Related]
19. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease. Wu Y; Ma KL; Zhang Y; Wen Y; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Ruan XZ; Liu BC Liver Int; 2016 Oct; 36(10):1525-34. PubMed ID: 27028410 [TBL] [Abstract][Full Text] [Related]
20. Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling. Tang H; Yu R; Liu S; Huwatibieke B; Li Z; Zhang W EBioMedicine; 2016 Apr; 6():139-148. PubMed ID: 27211556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]